PRESENTATION · Sep 2025 · PDF

Acoramidis-HFSA-2025-VA-Incidence-of-ATTR-CM-by-State

PRESENTATION · Sep 2025 · PDF

Acoramidis-HFSA-2025-Effect-on-CVM_Recurrent-CVH-Cumulative-Incidence-Oral-Presentation

PRESENTATION · Sep 2025 · PDF

Acoramidis-HFSA-2025-NT-proBNP-in-ATTRv-CM

PRESENTATION · Sep 2025 · PDF

Acoramidis-HFSA-2025-OLE-ACM-and-CVH-by-Genotype

PRESENTATION · Sep 2025 · PDF

Acoramidis-HFSA-2025-Cardiac-Conduction-abnormalities

PRESENTATION · Sep 2025 · PDF

Encaleret - Chronic Hypoparathyroidism - Proof of Concept Study in Post-Surgical Hypoparathyroidism

PRESENTATION · Sep 2025 · PDF

Infigratinib - Crouzon/Pfeiffer Syndromes - Preclinical Improvement in Skull Measures

PRESENTATION · Sep 2025 · PDF

Infigratinib - Hypochondroplasia - Preclinical Improvement in Bone Growth

PRESENTATION · Aug 2025 · PDF

BBIO - Acoramidis TTR- ESC 2025 - Improvement in NT-proBNP

PRESENTATION · Aug 2025 · PDF

BBIO - Acoramidis TTR - ESC 2025 - Stable/Improved NAC at Month 30